2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
26
Recruiting
19
Unknown
8
Active not recruiting
8
Terminated
4
Withdrawn
3
Not yet recruiting
3
Enrolling by invitation
1
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Pelvic Organ Prolapse
1
Leukemia, Myeloid, Acute
1
Leiomyoma
1
Endometrial Hyperplasia
1
Dupuytren Contracture
1
Interventions
Cisplatin
122
Carboplatin
121
Drug Therapy
118
Bevacizumab
105
Capecitabine
99
Oxaliplatin
97
Radiotherapy
95
Paclitaxel
88
Gemcitabine
88
tislelizumab
87
Cyclophosphamide
86
Specimen Handling
80
pembrolizumab
76
toripalimab
67
Magnetic Resonance Spectroscopy
65
Fluorouracil
62
sintilimab
59
Injections
57
Surgical Procedures, Operative
56
Docetaxel
54
anlotinib
51
130-nm albumin-bound paclitaxel
48
Immune Checkpoint Inhibitors
47
fludarabine
46
Standard of Care
45
Pemetrexed
43
Blood Specimen Collection
43
Biopsy
43
venetoclax
41
lenvatinib
41
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Restraint, Physical
×
Clear all
NCT07353060
2026-01-20
PRODUCT
Ramsay Générale de Santé
Phase NA
Not yet recruiting
305 enrolled
NCT07137299
2025-08-22
POP-LAP
Medical University of Silesia
Not yet recruiting
2,000 enrolled
NCT06786897
2025-01-22
ERAPH
University Hospital, Montpellier
Not yet recruiting
37 enrolled